VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,148,122 | -26.0% | 205,223 | +14.8% | 0.00% | – |
| Q2 2023 | $4,252,487 | -34.4% | 178,751 | -29.9% | 0.00% | -100.0% |
| Q1 2023 | $6,482,647 | +92.4% | 254,821 | +120.9% | 0.00% | – |
| Q4 2022 | $3,370,192 | +189.8% | 115,378 | +103.5% | 0.00% | – |
| Q3 2022 | $1,163,000 | +755.1% | 56,696 | +383.4% | 0.00% | – |
| Q2 2022 | $136,000 | -58.8% | 11,729 | -34.2% | 0.00% | – |
| Q1 2022 | $330,000 | +75.5% | 17,833 | +87.4% | 0.00% | – |
| Q4 2021 | $188,000 | +6166.7% | 9,514 | +5399.4% | 0.00% | – |
| Q3 2021 | $3,000 | – | 173 | +981.2% | 0.00% | – |
| Q1 2021 | $0 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |